Cargando…
MicroRNAs in the Myelodysplastic Syndrome
The myelodysplastic syndrome (MDS) holds a special place among blood cancers, as it represents a whole spectrum of hematological disorders with impaired differentiation of hematopoietic precursors, bone marrow dysplasia, genetic instability and is noted for an increased risk of acute myeloid leukemi...
Autores principales: | Veryaskina, Y. A., Titov, S. E., Kovynev, I. B., Fedorova, S. S., Pospelova, T. I., Zhimulev, I. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327150/ https://www.ncbi.nlm.nih.gov/pubmed/34377552 http://dx.doi.org/10.32607/actanaturae.11209 |
Ejemplares similares
-
Prognostic Markers of Myelodysplastic Syndromes
por: Veryaskina, Yuliya Andreevna, et al.
Publicado: (2020) -
The Profile of MicroRNA Expression in Bone Marrow in Non-Hodgkin’s Lymphomas
por: Veryaskina, Yuliya A., et al.
Publicado: (2022) -
Profiling 25 Bone Marrow microRNAs in Acute Leukemias and Secondary Nonleukemic Hematopoietic Conditions
por: Kovynev, Igor B., et al.
Publicado: (2020) -
MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas
por: Veryaskina, Yuliya A., et al.
Publicado: (2023) -
Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer
por: Veryaskina, Yuliya A., et al.
Publicado: (2022)